SPM Corporation (HOSE:SPM)
Vietnam
· Delayed Price · Currency is VND 8,510.00
0.00 (0.00%)
At close: Apr 24, 2026
SPM Corporation Revenue
SPM Corporation had revenue of 46.01B VND in the quarter ending March 31, 2026, a decrease of -44.24%. This brings the company's revenue in the last twelve months to 217.45B, down -27.86% year-over-year. In the year 2025, SPM Corporation had annual revenue of 253.96B, down -14.72%.
Revenue (ttm)
217.45B
Revenue Growth
-27.86%
P/S Ratio
0.54
Revenue / Employee
869.79M
Employees
250
Market Cap
117.18B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 253.96B | -43.82B | -14.72% |
| Dec 31, 2024 | 297.78B | -108.33B | -26.68% |
| Dec 31, 2023 | 406.10B | -293.53B | -41.95% |
| Dec 31, 2022 | 699.63B | -10.26B | -1.44% |
| Dec 31, 2021 | 709.89B | 99.90B | 16.38% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2013 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lamdong Pharmaceutical JSC | 242.87B |
| Phong Phu Pharmaceutical JSC | 139.74B |
| Cai Lay Veterinary Pharmaceutical JSC | 152.40B |
| American Vietnamese Biotech Incorporation | 154.07B |
| Vimedimex Medi-Pharma JSC | 812.98B |
| Ben Tre Pharmaceutical JSC | 860.31B |
| Mediplantex National Pharmaceutical JSC | 366.83B |
| Vidipha Central Pharmaceutical JSC | 971.25B |